Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michael C. Swett"'
Autor:
Ivan Urits, Daniel Swanson, Michael C. Swett, Anjana Patel, Kevin Berardino, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Alan D. Kaye, Omar Viswanath
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Abstract Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000–10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cau
Externí odkaz:
https://doaj.org/article/d4411de9a7a947deab62328df510341a
Autor:
Omar Viswanath, Amnon A Berger, Elyse M. Cornett, Michael C Swett, Ivan Urits, Melis Yilmaz, Karina Charipova, Hisham Kassem, Ehab Bahrum, Anh L. Ngo, Alan D. Kaye, Kyle Gress
Publikováno v:
Neurology and Therapy
Neurology and Therapy, Vol 9, Iss 2, Pp 403-417 (2020)
Neurology and Therapy, Vol 9, Iss 2, Pp 403-417 (2020)
Purpose of Review This is a comprehensive review of the current literature on the usage of galcanezumab for migraine treatment. It reviews the biology, pathophysiology, epidemiology, diagnosis, and conventional treatment of migraines, then compares t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9ddf4ff297487195a6edcb06dd907e
https://doi.org/10.1007/s40120-020-00214-3
https://doi.org/10.1007/s40120-020-00214-3
Autor:
Omar Viswanath, Hisham Kassem, Alan D. Kaye, Daniel Swanson, Anjana Patel, Michael C Swett, Ariunzaya Amgalan, Ivan Urits, Amnon A Berger, Kevin Berardino
Publikováno v:
Neurology and Therapy
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Neurology and Therapy, Vol 9, Iss 2, Pp 301-315 (2020)
Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000–10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cause protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e61701f432dddc09bce74fff535eaed
http://europepmc.org/articles/PMC7606409
http://europepmc.org/articles/PMC7606409
Autor:
Omar Viswanath, Hisham Kassem, Daniel Swanson, Ariunzaya Amgalan, Alan D. Kaye, Ivan Urits, Amnon A Berger, Kevin Berardino, Anjana Patel, Michael C Swett
Publikováno v:
Neurology and Therapy
Hereditary variant transthyretin amyloidosis (ATTRv) is a rare genetic defect that affects about 5000-10,000 people worldwide, causing amyloidosis secondary to misfolding of mutant transthyretin (TTR) protein fibrils. TTR mutations can cause protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e24edfa684ae10330602c8058d4eba5
https://doi.org/10.1007/s40120-020-00228-x
https://doi.org/10.1007/s40120-020-00228-x
Autor:
Urits, Ivan1 (AUTHOR) iurits@bidmc.harvard.edu, Swanson, Daniel2 (AUTHOR), Swett, Michael C.2 (AUTHOR), Patel, Anjana2 (AUTHOR), Berardino, Kevin2 (AUTHOR), Amgalan, Ariunzaya2 (AUTHOR), Berger, Amnon A.1 (AUTHOR), Kassem, Hisham3 (AUTHOR), Kaye, Alan4 (AUTHOR), Viswanath, Omar5,6,7 (AUTHOR)
Publikováno v:
Neurology & Therapy. Dec2020, Vol. 9 Issue 2, p301-315. 15p.
Publikováno v:
Drug Week; 9/6/2024, p2368-2368, 1p
Autor:
Urits, Ivan1 (AUTHOR) iurits@bidmc.harvard.edu, Swanson, Daniel2 (AUTHOR), Swett, Michael C.2 (AUTHOR), Patel, Anjana2 (AUTHOR), Berardino, Kevin2 (AUTHOR), Amgalan, Ariunzaya2 (AUTHOR), Berger, Amnon A.1 (AUTHOR), Kassem, Hisham3 (AUTHOR), Kaye, Alan D.4 (AUTHOR), Viswanath, Omar5,6,7 (AUTHOR)
Publikováno v:
Neurology & Therapy. Jun2021, Vol. 10 Issue 1, p407-407. 1p.
Autor:
Shrikaant Kulkarni
This book discusses how greener synthetic pathways are amenable and productive for the synthesis of novel nanomaterials. It furthers the integration of advances in green nanoscience and nanotechnology, including pathways dedicated to the design, deve
